The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery.
暂无分享,去创建一个
[1] Bradley S Moore,et al. Sioxanthin, a novel glycosylated carotenoid, reveals an unusual subclustered biosynthetic pathway. , 2015, Environmental microbiology.
[2] M. Hodson,et al. LC-MS-Based Metabolomics Study of Marine Bacterial Secondary Metabolite and Antibiotic Production in Salinispora arenicola , 2015, Marine drugs.
[3] B. Moore,et al. Direct Capture and Heterologous Expression of Salinispora Natural Product Genes for the Biosynthesis of Enterocin , 2014, Journal of natural products.
[4] S. Brady,et al. Mining Soil Metagenomes to Better Understand the Evolution of Natural Product Structural Diversity: Pentangular Polyphenols as a Case Study , 2014, Journal of the American Chemical Society.
[5] Amy L. Lane,et al. Characterization of an Orphan Diterpenoid Biosynthetic Operon from Salinispora arenicola , 2014, Journal of natural products.
[6] Li Zha,et al. Discovery of the lomaiviticin biosynthetic gene cluster in Salinispora pacifica. , 2014, Tetrahedron.
[7] M. Hodson,et al. Effects of salinity on antibiotic production in sponge‐derived Salinispora actinobacteria , 2014, Journal of applied microbiology.
[8] Pieter C. Dorrestein,et al. Mass spectrometry of natural products: current, emerging and future technologies. , 2014, Natural product reports.
[9] P. Glazer,et al. The cytotoxicity of (–)-lomaiviticin A arises from induction of double-strand breaks in DNA , 2014, Nature chemistry.
[10] M. Hodson,et al. Discovering the Recondite Secondary Metabolome Spectrum of Salinispora Species: A Study of Inter-Species Diversity , 2014, PloS one.
[11] Krystle L. Chavarria,et al. Diversity and evolution of secondary metabolism in the marine actinomycete genus Salinispora , 2014, Proceedings of the National Academy of Sciences.
[12] W. Hopper,et al. Biological Activity of Sporolides A and B from Salinispora tropica: in silico Target Prediction Using Ligand‐Based Pharmacophore Mapping and in vitro activity Validation on HIV‐1 Reverse Transcriptase , 2014, Chemical biology & drug design.
[13] M. Hodson,et al. Bacterial production of the fungus-derived cholesterol-lowering agent mevinolin. , 2014, Biomedical chromatography : BMC.
[14] E. Balskus,et al. Lomaiviticin biosynthesis employs a new strategy for starter unit generation. , 2014, Organic letters.
[15] Bradley S Moore,et al. Glycogenomics as a mass spectrometry-guided genome-mining method for microbial glycosylated molecules , 2013, Proceedings of the National Academy of Sciences.
[16] M. Tsuda,et al. Salinisporaarenicola from temperate marine sediments: new intra-species variations and atypical distribution of secondary metabolic genes , 2013, Antonie van Leeuwenhoek.
[17] R. Codd,et al. The variable hydroxamic acid siderophore metabolome of the marine actinomycete Salinispora tropica CNB-440. , 2013, Metallomics : integrated biometal science.
[18] P. Jensen,et al. Multilocus Sequence Typing Reveals Evidence of Homologous Recombination Linked to Antibiotic Resistance in the Genus Salinispora , 2013, Applied and Environmental Microbiology.
[19] David C. Smith,et al. Targeted search for actinomycetes from nearshore and deep-sea marine sediments. , 2013, FEMS microbiology ecology.
[20] Amy L. Lane,et al. Bioactivity‐Guided Genome Mining Reveals the Lomaiviticin Biosynthetic Gene Cluster in Salinispora tropica , 2013, Chembiochem : a European journal of chemical biology.
[21] Amy L. Lane,et al. Structures and comparative characterization of biosynthetic gene clusters for cyanosporasides, enediyne-derived natural products from marine actinomycetes. , 2013, Journal of the American Chemical Society.
[22] C. Hertweck,et al. A genomic approach to the cryptic secondary metabolome of the anaerobic world. , 2013, Natural product reports.
[23] Paul R. Jensen,et al. Salinispora pacifica sp. nov., an actinomycete from marine sediments , 2013, Antonie van Leeuwenhoek.
[24] P. Dorrestein,et al. Iron acquisition in the marine actinomycete genus Salinispora is controlled by the desferrioxamine family of siderophores. , 2012, FEMS microbiology letters.
[25] B. Moore,et al. Mechanistic studies on CymD: a tryptophan reverse N-prenyltransferase. , 2012, Biochemistry.
[26] J. Janso,et al. Isolation of lomaiviticins C-E, transformation of lomaiviticin C to lomaiviticin A, complete structure elucidation of lomaiviticin A, and structure-activity analyses. , 2012, Journal of the American Chemical Society.
[27] S. Tomasi,et al. When the nine-membered enediynes play hide and seek. , 2012, Organic & biomolecular chemistry.
[28] K. Penn,et al. Genetic Complementation of the Obligate Marine Actinobacterium Salinispora tropica with the Large Mechanosensitive Channel Gene mscL Rescues Cells from Osmotic Downshock , 2012, Applied and Environmental Microbiology.
[29] K. Penn,et al. Comparative genomics reveals evidence of marine adaptation in Salinispora species , 2012, BMC Genomics.
[30] Anna Edlund,et al. Microdiversity and evidence for high dispersal rates in the marine actinomycete 'Salinispora pacifica'. , 2012, Environmental microbiology.
[31] W. Marsden. I and J , 2012 .
[32] Y. Ng,et al. Developmental cycle and pharmaceutically relevant compounds of Salinispora actinobacteria isolated from Great Barrier Reef marine sponges , 2012, Applied Microbiology and Biotechnology.
[33] Anna Lechner,et al. Selective overproduction of the proteasome inhibitor salinosporamide A via precursor pathway regulation. , 2011, Chemistry & biology.
[34] M. Vidgen,et al. Diversity and distribution of the bioactive actinobacterial genus Salinispora from sponges along the Great Barrier Reef , 2011, Antonie van Leeuwenhoek.
[35] B. Moore,et al. Bacterial self-resistance to the natural proteasome inhibitor salinosporamide A. , 2011, ACS Chemical Biology.
[36] Pieter C. Dorrestein,et al. A mass spectrometry-guided genome mining approach for natural product peptidogenomics , 2011, Nature chemical biology.
[37] William Fenical,et al. Evolution of Secondary Metabolite Genes in Three Closely Related Marine Actinomycete Species , 2011, Applied and Environmental Microbiology.
[38] B. Moore,et al. Discovery and assembly-line biosynthesis of the lymphostin pyrroloquinoline alkaloid family of mTOR inhibitors in Salinispora bacteria. , 2011, Journal of the American Chemical Society.
[39] R. Müller,et al. Mining the Cinnabaramide Biosynthetic Pathway to Generate Novel Proteasome Inhibitors , 2011, Chembiochem : a European journal of chemical biology.
[40] P. Richardson,et al. Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. , 2011, Current cancer drug targets.
[41] S. Herzon,et al. 11-Step enantioselective synthesis of (-)-lomaiviticin aglycon. , 2011, Journal of the American Chemical Society.
[42] Micheal C. Wilson,et al. The Discovery of Salinosporamide K from the Marine Bacterium “Salinispora pacifica” by Genome Mining Gives Insight into Pathway Evolution , 2011, Chembiochem : a European journal of chemical biology.
[43] B. Moore,et al. Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics. , 2010, Angewandte Chemie.
[44] B. Degnan,et al. Diversity of Mycobacterium species from marine sponges and their sensitivity to antagonism by sponge-derived rifamycin-synthesizing actinobacterium in the genus Salinispora. , 2010, FEMS microbiology letters.
[45] K. Shin‐ya,et al. Streptomyces tateyamensis sp. nov., Streptomyces marinus sp. nov. and Streptomyces haliclonae sp. nov., isolated from the marine sponge Haliclona sp. , 2010, International journal of systematic and evolutionary microbiology.
[46] C. Walsh,et al. Prephenate decarboxylases: a new prephenate-utilizing enzyme family that performs nonaromatizing decarboxylation en route to diverse secondary metabolites. , 2010, Biochemistry.
[47] B. Moore,et al. Characterization of 5-Chloro-5-Deoxy-d-Ribose 1-Dehydrogenase in Chloroethylmalonyl Coenzyme A Biosynthesis , 2010, The Journal of Biological Chemistry.
[48] Micheal C. Wilson,et al. Shared biosynthesis of the saliniketals and rifamycins in Salinispora arenicola is controlled by the sare1259-encoded cytochrome P450. , 2010, Journal of the American Chemical Society.
[49] K. Nicolaou,et al. Total synthesis of sporolide B and 9-epi-sporolide B. , 2010, Journal of the American Chemical Society.
[50] P. Jensen,et al. Saliniquinones A-F, New Members of the Highly Cytotoxic Anthraquinone-γ-Pyrones from the Marine Actinomycete Salinispora arenicola. , 2010, Australian journal of chemistry.
[51] Xiaole Kong,et al. Chemistry and biology of siderophores. , 2010, Natural product reports.
[52] Bradley S. Moore,et al. Engineering fluorometabolite production: fluorinase expression in Salinispora tropica Yields Fluorosalinosporamide. , 2010, Journal of natural products.
[53] K. S. Lam,et al. Generating a Generation of Proteasome Inhibitors: From Microbial Fermentation to Total Synthesis of Salinosporamide A (Marizomib) and Other Salinosporamides , 2010, Marine drugs.
[54] B. Moore,et al. Functional characterization of the cyclomarin/cyclomarazine prenyltransferase CymD directs the biosynthesis of unnatural cyclic peptides. , 2010, Journal of natural products.
[55] T. Kirkland,et al. Arenimycin, an antibiotic effective against rifampin- and methicillin-resistant Staphylococcus aureus from the marine actinomycete Salinispora arenicola , 2010, The Journal of Antibiotics.
[56] Ginger Tsueng,et al. A preliminary investigation on the growth requirement for monovalent cations, divalent cations and medium ionic strength of marine actinomycete Salinispora , 2010, Applied Microbiology and Biotechnology.
[57] J. Yadav,et al. Formal total synthesis of (-)-saliniketals. , 2009, The Journal of organic chemistry.
[58] B. Moore,et al. Function-oriented biosynthesis of beta-lactone proteasome inhibitors in Salinispora tropica. , 2009, Journal of medicinal chemistry.
[59] Y. Matsuo,et al. Salinisporamycin, a novel metabolite from Salinispora arenicora , 2009, The Journal of Antibiotics.
[60] J. D. De Brabander,et al. A concise total synthesis of saliniketal B. , 2009, Journal of the American Chemical Society.
[61] B. Moore,et al. Biosynthesis of salinosporamides from alpha,beta-unsaturated fatty acids: implications for extending polyketide synthase diversity. , 2009, Journal of the American Chemical Society.
[62] Anna Lechner,et al. Biosynthesis of the salinosporamide A polyketide synthase substrate chloroethylmalonyl-coenzyme A from S-adenosyl-l-methionine , 2009, Proceedings of the National Academy of Sciences.
[63] G. Challis,et al. New natural product biosynthetic chemistry discovered by genome mining. , 2009, Natural product reports.
[64] J. Vederas,et al. Drug Discovery and Natural Products: End of an Era or an Endless Frontier? , 2009, Science.
[65] Bradley S. Moore,et al. Exploration and engineering of biosynthetic pathways in the marine actinomycete Salinispora tropica , 2009 .
[66] Shukun Tang,et al. Marinactinospora thermotolerans gen. nov., sp. nov., a marine actinomycete isolated from a sediment in the northern South China Sea. , 2009, International journal of systematic and evolutionary microbiology.
[67] Alla Lapidus,et al. Genomic islands link secondary metabolism to functional adaptation in marine Actinobacteria , 2009, The ISME Journal.
[68] J. Pezzuto,et al. Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola. , 2009, Journal of natural products.
[69] K. S. Lam,et al. Discovery and development of the anticancer agent salinosporamide A (NPI-0052). , 2009, Bioorganic & medicinal chemistry.
[70] S. Neuteboom,et al. Antiprotealide is a natural product. , 2009, Journal of natural products.
[71] Shukun Tang,et al. Sciscionella marina gen. nov., sp. nov., a marine actinomycete isolated from a sediment in the northern South China Sea. , 2009, International journal of systematic and evolutionary microbiology.
[72] Susana P. Gaudêncio,et al. The ammosamides: structures of cell cycle modulators from a marine-derived Streptomyces species. , 2009, Angewandte Chemie.
[73] Philip G. Williams,et al. Panning for chemical gold: marine bacteria as a source of new therapeutics. , 2009, Trends in biotechnology.
[74] Ginger Tsueng,et al. Growth of Salinispora tropica strains CNB440, CNB476, and NPS21184 in nonsaline, low-sodium media , 2008, Applied Microbiology and Biotechnology.
[75] E. Anderson,et al. Total synthesis of (-)-saliniketals A and B. , 2008, Organic letters.
[76] Alejandra Prieto-Davó,et al. Comparative actinomycete diversity in marine sediments , 2008 .
[77] B. Moore,et al. Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors. , 2008, Journal of the American Chemical Society.
[78] Bradley S Moore,et al. Mutasynthesis of fluorosalinosporamide, a potent and reversible inhibitor of the proteasome. , 2008, Angewandte Chemie.
[79] D. Kuhn,et al. Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade , 2008, Clinical Cancer Research.
[80] William Fenical,et al. Biosynthesis and structures of cyclomarins and cyclomarazines, prenylated cyclic peptides of marine actinobacterial origin. , 2008, Journal of the American Chemical Society.
[81] D. Oh,et al. Salinipyrones and pacificanones, mixed-precursor polyketides from the marine actinomycete Salinispora pacifica. , 2008, Journal of natural products.
[82] K. Nicolaou,et al. Synthesis of the sporolide ring framework through a cascade sequence involving an intramolecular [4+2] cycloaddition reaction of an o-quinone. , 2008, Angewandte Chemie.
[83] Sy Teisan,et al. Defined salt formulations for the growth of Salinispora tropica strain NPS21184 and the production of salinosporamide A (NPI-0052) and related analogs , 2008, Applied Microbiology and Biotechnology.
[84] Ginger Tsueng,et al. A low-sodium-salt formulation for the fermentation of salinosporamides by Salinispora tropica strain NPS21184 , 2008, Applied Microbiology and Biotechnology.
[85] B. Moore,et al. Unraveling the biosynthesis of the sporolide cyclohexenone building block. , 2008, Journal of the American Chemical Society.
[86] B. Moore,et al. Discovery and characterization of a marine bacterial SAM-dependent chlorinase. , 2008, Nature chemical biology.
[87] A. Shindia. Mevinolin production by some fungi , 2008, Folia Microbiologica.
[88] A. Bull,et al. Marine actinobacteria: new opportunities for natural product search and discovery. , 2007, Trends in microbiology.
[89] P. Williams,et al. Arenicolides A-C, 26-membered ring macrolides from the marine actinomycete Salinispora arenicola. , 2007, The Journal of organic chemistry.
[90] William Fenical,et al. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica , 2007, Proceedings of the National Academy of Sciences.
[91] Tae Kyung Kim,et al. Screening of rifamycin producing marine sponge bacteria by LC-MS-MS. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[92] C. Perrin,et al. Nucleophilic addition to a p-benzyne derived from an enediyne: a new mechanism for halide incorporation into biomolecules. , 2007, Journal of the American Chemical Society.
[93] B. Moore,et al. Biosynthetic convergence of salinosporamides A and B in the marine actinomycete Salinispora tropica. , 2007, Organic letters.
[94] P. Reinemer,et al. Cinnabaramides A-G: analogues of lactacystin and salinosporamide from a terrestrial streptomycete. , 2007, Journal of natural products.
[95] Sy Teisan,et al. Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome. , 2007, Journal of natural products.
[96] J. Pezzuto,et al. Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. , 2007, Journal of natural products.
[97] William Fenical,et al. Species-Specific Secondary Metabolite Production in Marine Actinomycetes of the Genus Salinispora , 2006, Applied and Environmental Microbiology.
[98] Paul R Jensen,et al. Developing a new resource for drug discovery: marine actinomycete bacteria , 2006, Nature chemical biology.
[99] Paul R Jensen,et al. Biogeography of the marine actinomycete Salinispora. , 2006, Environmental microbiology.
[100] K. S. Lam,et al. Discovery of novel metabolites from marine actinomycetes. , 2006, Current opinion in microbiology.
[101] R. Huber,et al. Crystal structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding. , 2006, Journal of the American Chemical Society.
[102] Amitha K. Hewavitharana,et al. Discovery of a New Source of Rifamycin Antibiotics in Marine Sponge Actinobacteria by Phylogenetic Prediction , 2006, Applied and Environmental Microbiology.
[103] D. Oh,et al. Cyanosporasides A and B, chloro- and cyano-cyclopenta[a]indene glycosides from the marine actinomycete "Salinispora pacifica". , 2006, Organic letters.
[104] T. Mincer,et al. Culture-Dependent and Culture-Independent Diversity within the Obligate Marine Actinomycete Genus Salinispora , 2005, Applied and Environmental Microbiology.
[105] William Fenical,et al. Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligate marine actinomycetes belonging to the family Micromonosporaceae. , 2005, International journal of systematic and evolutionary microbiology.
[106] T. Mincer,et al. Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. , 2005, Environmental microbiology.
[107] P. Williams,et al. New cytotoxic salinosporamides from the marine Actinomycete Salinispora tropica. , 2005, The Journal of organic chemistry.
[108] P. Williams,et al. Sporolides A and B: structurally unprecedented halogenated macrolides from the marine actinomycete Salinispora tropica. , 2005, Organic letters.
[109] E. Corey,et al. An efficient, stereocontrolled synthesis of a potent omuralide-salinosporin hybrid for selective proteasome inhibition. , 2005, Journal of the American Chemical Society.
[110] S. Danishefsky,et al. Total synthesis of salinosporamide A. , 2005, Journal of the American Chemical Society.
[111] S. Neuteboom,et al. Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor. , 2005, Journal of medicinal chemistry.
[112] M. Garson,et al. Marine actinomycetes related to the "Salinospora" group from the Great Barrier Reef sponge Pseudoceratina clavata. , 2005, Environmental microbiology.
[113] F. Koehn,et al. The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.
[114] H. Floss,et al. Rifamycin-mode of action, resistance, and biosynthesis. , 2005, Chemical reviews.
[115] János Bérdy,et al. Bioactive microbial metabolites. , 2005, The Journal of antibiotics.
[116] J. Chun,et al. Serinicoccus marinus gen. nov., sp. nov., a novel actinomycete with L-ornithine and L-serine in the peptidoglycan. , 2004, International journal of systematic and evolutionary microbiology.
[117] J. Naismith,et al. Crystal structure and mechanism of a bacterial fluorinating enzyme , 2004, Nature.
[118] Jay D. Keasling,et al. Metabolic engineering for drug discovery and development , 2003, Nature Reviews Drug Discovery.
[119] V. Mikhailov,et al. Salinibacterium amurskyense gen. nov., sp. nov., a novel genus of the family Microbacteriaceae from the marine environment. , 2003, International journal of systematic and evolutionary microbiology.
[120] T. Mincer,et al. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora. , 2003, Angewandte Chemie.
[121] William Fenical,et al. Widespread and Persistent Populations of a Major New Marine Actinomycete Taxon in Ocean Sediments , 2002, Applied and Environmental Microbiology.
[122] A. Richardson,et al. Lomaiviticins A and B, potent antitumor antibiotics from Micromonospora lomaivitiensis. , 2001, Journal of the American Chemical Society.
[123] C Hertweck,et al. Cloning, sequencing and analysis of the enterocin biosynthesis gene cluster from the marine isolate 'Streptomyces maritimus': evidence for the derailment of an aromatic polyketide synthase. , 2000, Chemistry & biology.
[124] William Fenical,et al. Cyclomarins A−C, New Antiinflammatory Cyclic Peptides Produced by a Marine Bacterium (Streptomyces sp.) , 1999 .
[125] E. Corey,et al. Total synthesis and biological activity of lactacystin, omuralide and analogs. , 1999, Chemical & pharmaceutical bulletin.
[126] H. Nagata,et al. Lymphostin (LK6-A), a novel immunosuppressant from Streptomyces sp. KY11783: structural elucidation. , 1997, The Journal of antibiotics.
[127] M. Moran,et al. Evidence for indigenous Streptomyces populations in a marine environment determined with a 16S rRNA probe , 1995, Applied and environmental microbiology.
[128] T. Otani,et al. Structure and cycloaromatization of a novel enediyne, C-1027 chromophore , 1993 .
[129] R. Hill,et al. Isolation and Diversity of Actinomycetes in the Chesapeake Bay , 1993, Applied and environmental microbiology.
[130] K. Nicolaou,et al. Chemistry and Biology of the Enediyne Anticancer Antibiotics , 1991 .
[131] P. Jensen,et al. Distribution of actinomycetes in near-shore tropical marine sediments , 1991, Applied and environmental microbiology.
[132] S. Ōmura,et al. Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells. , 1991, The Journal of antibiotics.
[133] S. Ōmura,et al. X-Ray crystal structure of staurosporine: a new alkaloid from a Streptomyces strain , 1978 .
[134] H. Weyland. Actinomycetes in North Sea and Atlantic Ocean Sediments , 1969, Nature.